Fact 4 of 5 in the story · Thursday 29 October, 08h35
Cancer research: between treatment promises and delays in access to care
Following the European oncology congress, Professor Jean-Jacques Kiladjian explains the gap between announcements of promising treatments and their effective access for patients.
In brief
Health event (severity: low) nationwide, first detected on 29 October 2026 at 08:35. Reported by 1 source (1 article), last updated on 29 October 2026 at 08:35. Part of the story “European oncology congress: therapeutic advances and access to care”.
- Category
- Health
- Severity
- Low
- Place
National
- Detected
- 29 Oct, 08h35
- Updated
- 29 Oct, 08h35
- Reference
- no.3625
What changed in the story at that point
1 article · 1 source · 1 bord sur 3 · outlets: left 1, centre 0, right 0
Angle comparison
A comparison is written as soon as the event is covered by at least two sides (left, centre, right).
Lire les sources · 1 article, 1 source
- 08h35LibérationLeftAnalysis29 Oct«Nous sommes pris entre deux injonctions» : la recherche contre le cancer, entre course contre la montre et accessibilité des soins
Dans la foulée du congrès européen de cancérologie et son lot d’annonces de traitements prometteurs, le professeur Jean-Jacques Kiladjian, directeur de recherche à l’Inserm, explique pourquoi plusieurs années s’écoulent avant leur accès au plus grand nombre.
Further reading
People cited
Organisations cited
Keywords
#cancer · #recherche · #accès aux soins
Go up the thread
In the same story
People and organisations cited